HealthEquity (NASDAQ:HQY) Coverage Initiated by Analysts at The Goldman Sachs Group

The Goldman Sachs Group assumed coverage on shares of HealthEquity (NASDAQ:HQYFree Report) in a research report report published on Friday morning, Marketbeat.com reports. The brokerage issued a neutral rating and a $108.00 target price on the stock.

A number of other research firms have also recently weighed in on HQY. Barrington Research reaffirmed an “outperform” rating and set a $105.00 target price on shares of HealthEquity in a research note on Friday, September 20th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price objective on shares of HealthEquity in a research note on Wednesday, September 4th. BTIG Research lifted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday. JMP Securities restated a “market outperform” rating and issued a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft lifted their price target on shares of HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $107.23.

Read Our Latest Analysis on HealthEquity

HealthEquity Price Performance

Shares of HQY stock traded up $3.28 on Friday, hitting $98.98. 1,561,907 shares of the company’s stock were exchanged, compared to its average volume of 620,201. The company has a 50 day moving average of $85.02 and a 200 day moving average of $81.07. The stock has a market cap of $8.64 billion, a P/E ratio of 82.48, a price-to-earnings-growth ratio of 1.48 and a beta of 0.52. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. HealthEquity has a 12 month low of $62.10 and a 12 month high of $101.17.

HealthEquity (NASDAQ:HQYGet Free Report) last posted its earnings results on Tuesday, September 3rd. The company reported $0.66 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. The firm had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. On average, equities research analysts predict that HealthEquity will post 2.27 EPS for the current year.

Insider Transactions at HealthEquity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert W. Selander sold 8,250 shares of the firm’s stock in a transaction that occurred on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the sale, the director now directly owns 54,719 shares of the company’s stock, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 10,536 shares of company stock valued at $884,517. Corporate insiders own 2.20% of the company’s stock.

Hedge Funds Weigh In On HealthEquity

A number of large investors have recently modified their holdings of the company. International Assets Investment Management LLC acquired a new position in HealthEquity during the 2nd quarter valued at about $35,000. Paladin Wealth LLC purchased a new position in shares of HealthEquity during the third quarter valued at approximately $39,000. GAMMA Investing LLC grew its holdings in HealthEquity by 114.8% during the second quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after buying an additional 318 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in HealthEquity in the 2nd quarter valued at $73,000. Finally, Quarry LP lifted its stake in HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after acquiring an additional 1,089 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Company Profile

(Get Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Articles

Analyst Recommendations for HealthEquity (NASDAQ:HQY)

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.